About Plethico Pharmaceuticals Ltd.
Data last updated:
Plethico Pharmaceuticals Ltd. is a public limited company based in Indore, Madhya Pradesh, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 04 December 1991.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN L24232MP1991PLC006801. The company has 2 GST registrations on record, none of which is active. It is recorded as listed by MCA, but its shares were delisted from NSE on 30 May 2018 · compulsory delisting and from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹34.07 Cr. It was formerly known as Plethico Pharmaceuticals Pvt Ltd. It is led by directors Shashikant Patel (Managing Director) and Jignesh Jitendra Panchal.
Its last annual general meeting (AGM) was held on 26 December 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office is at A.B. Road Manglia, Indore, Madhya Pradesh, India – 453771.
The company has about 665 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Plethico. As per MCA filings, the company has open charges of ₹754 Cr and satisfied charges of ₹350.95 Cr on record. Court records list 83 cases involving the company, including 21 filed by the company and 62 filed against it; 11 cases are pending. The company has 7 deals on record (4 secondary share transfers, 1 ipo, 1 acquisition); the latest was in November 2015.
The last known website on record is plethico.com.
Company details
Contact details
Plethico Pharmaceuticals Ltd.'s registered office is in Indore, Madhya Pradesh.
- Registered AddressA.B. Road Manglia, Indore, Madhya Pradesh, India – 453771
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Plethico Pharmaceuticals operates one associated brand: Plethico. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Health supplements, beauty products, and slimming solutions through online content and reviews. | plethico.com |
Financials of Plethico Pharmaceuticals Ltd.
FY 2014 filings availableFinancial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Plethico Pharmaceuticals Ltd., buy the company report.
Board of directors of Plethico Pharmaceuticals Ltd.
Plethico Pharmaceuticals has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jignesh Jitendra Panchal | Additional Director | 14 Jan 2016 | 10 Years 9 Months | As last reported |
| Shashikant Patel | Managing Director | 04 Dec 1991 | 34 Years 10 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Apr 2015 | 10586001 | Allahabad Bank | ₹115 Cr | Open | |
| 29 Jun 2011 | 10342667 | Allahabad Bank | ₹100 Cr | Open | |
| 28 Mar 2011 | 10284975 | Idbi Bank Limited | ₹10 Cr | Open | |
| 08 Mar 2011 | 10279768 | Allahabad Bank | ₹30 Cr | Open | |
| 25 Sep 2010 | 10244511 | Punjab National Bank | ₹30 Cr | Open |
To see the full charge records of Plethico Pharmaceuticals Ltd., buy the company report.
Total charge records: 38 View all charges
Deals & funding
Plethico Pharmaceuticals Ltd. has 7 deals on record (4 secondary share transfers, 1 ipo, 1 acquisition); the latest was in November 2015.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2015 | Market trade | ₹31.4 Lakh | Seller: Sicom Limited |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Hypnos Fund Limited Seller: Elara Capital |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Elara Capital Seller: Mavi Investment, an individual |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: Mavi Investment, an individual Seller: Goldman Sachs Public Market Fund |
| Jan 2003 | Acquisition | ₹84.81 Cr | Buyer: Shreya Life Sciences Private Limited |
To see the full deal history of Plethico Pharmaceuticals Ltd., buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Plethico Pharmaceuticals Ltd. has 83 court cases on record: 21 filed by Plethico Pharmaceuticals, 62 filed against it. 11 cases are pending and 72 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 66 | 52 | 10 |
| High courts | 14 | 8 | 1 |
| Supreme Court | 3 | 2 | 0 |
Cases on record (5 of 83)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by M/S Nakoda Dairy Pvt Ltd | Pending |
| Supreme Court | Court case (2903-Simple Money & Mortgage Matters Etc. : Others) | Filed against the company by M/S Zenith Drugs and Allied Agencies Pvt. Ltd. Managing Director Mahabir Prasad Bhimsaria 533, K.C. Chowdhury Road, Guwahati , District: Guwahati ,Kamrup , Assam | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Sicom Ltd | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Aarti Industries Ltd and 2 others | Disposed |
| High Court of Delhi | Court case (EX.P.) | Filed against the company by Akums Drugs & Pharmaceuticals Ltd | Disposed |
To see the full case history of Plethico Pharmaceuticals Ltd., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Plethico Pharmaceuticals Ltd.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Plethico Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Plethico Pharmaceuticals Ltd., buy the company report.
Recent activity
Plethico Pharmaceuticals Ltd. has 28 board changes on record since 1991: 15 appointments and 13 cessations. The latest: Milindkuamr Laxmishankar Dixit ceased to be Additional Director on 21 Oct 2016.
90 earlier events are in the company report.
Frequently asked questions
Plethico Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Plethico Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Indore, Madhya Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 04 December 1991 and is registered under CIN L24232MP1991PLC006801. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Plethico Pharmaceuticals has 2 current directors:
- Shashikant Patel - Managing Director
- Jignesh Jitendra Panchal - Additional Director
The latest financial statements of Plethico Pharmaceuticals on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 26 December 2014. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Plethico Pharmaceuticals is L24232MP1991PLC006801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Plethico Pharmaceuticals is recorded as a listed company by MCA, but its shares were delisted from NSE on 30 May 2018 · compulsory delisting and from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.
Plethico Pharmaceuticals has open charges of ₹754 Cr and satisfied charges of ₹350.95 Cr as per latest MCA filings.
Plethico Pharmaceuticals has 83 court cases on record: 21 filed by the company and 62 filed against it. 11 are pending. Most are in the district courts.
Plethico Pharmaceuticals was incorporated on 04 December 1991. It is registered with the Registrar of Companies, Gwalior.
Plethico Pharmaceuticals has 7 deals on record (4 secondary share transfers, 1 ipo, 1 acquisition); the latest was in November 2015.